LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients With Molecular Low-Risk Early-Stage Breast Cancer
OPEN TO ACCRUAL
III
NCT06671912
skumar4@brownhealth.org
